LONDON MARKET CLOSE: Blue chips fall but FTSE 250 extends winning run
(Alliance News) - The FTSE 100 fell on Thursday despite well-received earnings, but mid-caps extended their recent gains, lifted by advances by WPP and easyJet. Read More
| Price | 11,844.00p on 12-08-2026 at 05:02:21 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12,100.00p |
| Sell | 11,800.00p |
| Last Trade: | Unknown 20.00 at 11,746.08639p |
| Day's Volume: | 0 |
| Last Close: | 11,844.00p |
| Open: | 0.00p |
| ISIN: | GB0009895292 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 10,784.00p - 15,730.00p |
| Market Capitalisation: | £183.69b |
| VWAP: | 0.00p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 20 | 11,746.08639p | Currency Conversion OTC Trade |
20:55:40 - 11-Aug-26 |
| Unknown* | 40 | 11,756.08117p | Currency Conversion OTC Trade |
20:55:03 - 11-Aug-26 |
| Unknown* | 5 | 11,760.48627p | Currency Conversion OTC Trade |
20:53:54 - 11-Aug-26 |
| Unknown* | 20 | 11,761.63382p | Currency Conversion OTC Trade |
20:52:10 - 11-Aug-26 |
| Unknown* | 4 | 11,776.77406p | Currency Conversion OTC Trade |
20:31:25 - 11-Aug-26 |
| Unknown* | 25 | 11,776.8481p | Currency Conversion OTC Trade |
20:25:48 - 11-Aug-26 |
| Unknown* | 0 | 11,797.44474p | Currency Conversion OTC Trade |
20:12:51 - 11-Aug-26 |
| Unknown* | 1 | 11,801.20574p | Currency Conversion OTC Trade |
19:48:56 - 11-Aug-26 |
| Unknown* | 0 | 11,801.98311p | SI Trade Currency Conversion |
19:29:21 - 11-Aug-26 |
| Unknown* | 0 | 11,804.94453p | SI Trade Currency Conversion |
19:28:35 - 11-Aug-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Aug 2026 3:05 pm | RNS | Admission of Further Securities to Trading |
| 3rd Aug 2026 3:00 pm | RNS | Total Voting Rights |
| 31st Jul 2026 7:30 am | RNS | Datroway approved in EU for TNBC |
| 27th Jul 2026 7:10 am | RNS | Update on Ultomiris Phase III trial in HSCT-TMA |
| 27th Jul 2026 7:05 am | RNS | Sone-Ve improved survival in gastric cancers |
| 27th Jul 2026 7:00 am | RNS | Half-year Financial Report |
| 23rd Jul 2026 7:00 am | RNS | Etcamah approved in the EU for ER+ breast cancer |
| 14th Jul 2026 7:00 am | RNS | AstraZeneca licenses novel EGFR inhibitor |
| 9th Jul 2026 7:00 am | RNS | Update on CARDIO-TTRansform Phase III trial |
| 1st Jul 2026 3:05 pm | RNS | Admission of Further Securities to Trading |